National promises to cut foreign aid to fund $604m Pharmac boost and cancer screenings

Election policy would redirect aid outside the Pacific into medicines and free screening

By LineZotpaper
Published
Read Time1 min
The National Party has pledged to reduce foreign aid outside the Pacific and make the Ministry of Foreign Affairs and Trade more efficient, redirecting the savings into a $604 million uplift in Pharmac's medicines budget and an expansion of free cancer screening, if it leads the next government.

Announcing the policy at the Allevia Hospital cancer treatment rooms in Auckland's Epsom on Tuesday morning, National said the plan touches on the turf of both its coalition partners while delivering what it described as the largest ever boost for new medicines.

Health spokesperson Simeon Brown said the party had "put patients back at the heart of the health system", and that National wanted "to go further, getting more medicines to Kiwis and catching cancer early, when it is most treatable".

The policy would fund a $604 million increase to Pharmac's medicines budget and the nationwide expansion of free screening, with savings drawn from cutting foreign aid outside the Pacific and efficiency measures at MFAT.

Prime Minister Christopher Luxon joined Brown at the announcement, which is part of National's campaign platform ahead of the 2026 election.

§

Analysis

Why This Matters

  • The proposal would reallocate public money away from overseas development assistance to domestic health spending, changing New Zealand's aid footprint outside the Pacific.
  • Pharmac funding and cancer screening wait times are major election issues for voters.
  • The policy overlaps with the interests of National's coalition partners, which may shape coalition negotiations after the election.

Background

The pledge is part of National's election platform for 2026. It frames the redistribution as putting patients first while streamlining the foreign affairs ministry. The proposal to focus aid on the Pacific reflects a long-standing NZ policy priority, but redirecting funds from other regions into domestic health marks a shift in emphasis.

Key Perspectives

National: Argues the plan delivers a significant boost to medicines funding and expands cancer screening, keeping patients at the centre of the health system. Coalition partners: The policy sits on turf shared with National's governing partners, and how it is received could influence post-election arrangements. Development and aid observers: Are likely to question the impact of reducing aid outside the Pacific and whether efficiency savings can be achieved as assumed.

What to Watch

  • The detailed costings and how the $604 million figure is calculated.
  • Reaction from MFAT and aid sector groups to the proposed efficiency cuts.
  • How the policy is received during the 2026 election campaign and in coalition talks.

Sources

Zotpaper

Written by software from the reporting listed above, scored by an automated standards desk, and published without a person reading it first. If something here is wrong, tell the editor and it will be put right.